Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CLPT ClearPoint Neuro	$11.85 +0.3%	$12.66	$5.11 ▼ $19.22	$331.53M	1.03	235,648 shs	151,657 shs
MGRM Monogram Orthopaedics	$2.41 -0.2%	$2.69	$1.92 ▼ $4.21	$85.83M	0.74	248,853 shs	131,397 shs
OM Outset Medical	$17.75 +1.0%	$13.40	$5.85 ▼ $72.60	$315.20M	1.9	109,003 shs	133,473 shs
TMCI Treace Medical Concepts	$5.72 -0.4%	$6.98	$4.54 ▼ $10.79	$359.92M	0.79	592,838 shs	256,470 shs

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CLPT ClearPoint Neuro	0.00%	-0.67%	-18.16%	-12.84%	+117.50%
MGRM Monogram Orthopaedics	0.00%	-6.15%	-15.57%	+3.39%	+22.61%
OM Outset Medical	0.00%	-1.11%	+44.90%	+77.23%	-68.28%
TMCI Treace Medical Concepts	0.00%	-2.04%	-20.66%	-34.25%	-2.04%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CLPT ClearPoint Neuro	1.6686 of 5 stars	3.5	2.0	2.0	0.0	0.6
MGRM Monogram Orthopaedics	3.4303 of 5 stars	3.8	5.0	3.0	1.7	0.6
OM Outset Medical	2.5157 of 5 stars	3.5	5.0	2.4	0.8	0.0
TMCI Treace Medical Concepts	2.1792 of 5 stars	3.1	1.0	1.7	4.2	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CLPT ClearPoint Neuro	3.00	Buy	$25.00	111.06% Upside
MGRM Monogram Orthopaedics	3.50	Strong Buy	$5.40	124.53% Upside
OM Outset Medical	3.00	Buy	$27.00	52.13% Upside
TMCI Treace Medical Concepts	2.29	Hold	$10.16	77.73% Upside

Current Analyst Ratings Breakdown

Latest MGRM, TMCI, CLPT, and OM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/21/2025	OM Outset Medical	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sector Perform ➝ Sector Perform	$14.00 ➝ $21.00
5/15/2025	OM Outset Medical	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
5/9/2025	TMCI Treace Medical Concepts	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$10.00 ➝ $8.60
5/8/2025	OM Outset Medical	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sector Perform ➝ Sector Perform	$12.00 ➝ $14.00
4/11/2025	TMCI Treace Medical Concepts	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$9.50 ➝ $8.00
4/1/2025	CLPT ClearPoint Neuro	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$19.00 ➝ $25.00
3/21/2025	OM Outset Medical	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$15.00
3/18/2025	MGRM Monogram Orthopaedics	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$5.40
3/18/2025	MGRM Monogram Orthopaedics	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$4.00 ➝ $5.40
3/13/2025	TMCI Treace Medical Concepts	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$10.00 ➝ $9.50
3/3/2025	TMCI Treace Medical Concepts	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$8.40 ➝ $10.00

(Data available from 6/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CLPT ClearPoint Neuro	$32.24M	10.28	N/A	N/A	$0.86 per share	13.77
MGRM Monogram Orthopaedics	$365.00K	235.15	N/A	N/A	$0.43 per share	5.59
OM Outset Medical	$115.27M	2.73	N/A	N/A	$2.45 per share	7.24
TMCI Treace Medical Concepts	$210.82M	1.70	N/A	N/A	$2.24 per share	2.55

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CLPT ClearPoint Neuro	-$22.09M	-$0.76	N/A	N/A	N/A	-59.64%	-62.10%	-38.39%	8/6/2025 (Estimated)
MGRM Monogram Orthopaedics	-$13.74M	-$0.45	N/A	N/A	N/A	N/A	-130.90%	-106.38%	8/13/2025 (Estimated)
OM Outset Medical	-$172.80M	-$29.15	N/A	∞	N/A	-112.57%	-175.64%	-38.61%	8/6/2025 (Estimated)
TMCI Treace Medical Concepts	-$49.53M	-$0.85	N/A	N/A	N/A	-30.33%	-51.12%	-26.36%	8/5/2025 (Estimated)

Latest MGRM, TMCI, CLPT, and OM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/14/2025	Q1 2025	MGRM Monogram Orthopaedics	-$0.12	-$0.10	+$0.02	-$0.10	N/A	N/A
5/13/2025	Q1 2025	CLPT ClearPoint Neuro	-$0.15	-$0.22	-$0.07	-$0.22	$8.21 million	$8.49 million
5/8/2025	Q1 2025	TMCI Treace Medical Concepts	-$0.31	-$0.25	+$0.06	-$0.25	$52.07 million	$52.57 million
5/7/2025	Q1 2025	OM Outset Medical	-$0.97	-$3.66	-$2.69	-$3.66	$27.81 million	$29.75 million
3/12/2025	Q4 2024	MGRM Monogram Orthopaedics	-$0.11	-$0.08	+$0.03	-$0.08	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CLPT ClearPoint Neuro	N/A	N/A	N/A	N/A	N/A
MGRM Monogram Orthopaedics	N/A	N/A	N/A	N/A	N/A
OM Outset Medical	N/A	N/A	N/A	N/A	N/A
TMCI Treace Medical Concepts	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CLPT ClearPoint Neuro	N/A	4.54	3.61
MGRM Monogram Orthopaedics	N/A	7.31	7.31
OM Outset Medical	4.12	6.49	5.04
TMCI Treace Medical Concepts	0.51	4.12	2.98

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CLPT ClearPoint Neuro	30.08%
MGRM Monogram Orthopaedics	0.45%
OM Outset Medical	N/A
TMCI Treace Medical Concepts	84.08%

Insider Ownership

Company	Insider Ownership
CLPT ClearPoint Neuro	6.97%
MGRM Monogram Orthopaedics	28.10%
OM Outset Medical	2.40%
TMCI Treace Medical Concepts	27.72%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CLPT ClearPoint Neuro	110	27.99 million	25.90 million	Optionable
MGRM Monogram Orthopaedics	28	35.69 million	24.67 million	Not Optionable
OM Outset Medical	520	17.72 million	51.50 million	Not Optionable
TMCI Treace Medical Concepts	250	62.89 million	47.08 million	Optionable

MGRM, TMCI, CLPT, and OM Headlines

Recent News About These Companies

Treace Medical Concepts, Inc. (TMCI) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before June 10, 2025

June 2 at 1:30 PM | accessnewswire.com

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical

June 2 at 1:09 PM | globenewswire.com

June 10, 2025 Deadline: Join Class Action Lawsuit Against Treace Medical Concepts, Inc. (TMCI) - Contact Levi & Korsinsky

June 2 at 12:30 PM | accessnewswire.com

Lost Money on Treace Medical Concepts, Inc. (TMCI)? Join Class Action Before June 10, 2025 - Contact Levi & Korsinsky

June 2 at 11:45 AM | accessnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Treace Medical Concepts, Inc. - TMCI

June 2 at 11:25 AM | globenewswire.com

Securities Lawsuit Alert: Treace Medical Concepts, Inc. (TMCI) - Contact Levi & Korsinsky Before June 10, 2025

June 2 at 10:15 AM | accessnewswire.com

Class Action Alert: Levi & Korsinsky Reminds Treace Medical Concepts, Inc. (TMCI) Investors of June 10, 2025 Deadline

June 2 at 8:25 AM | accessnewswire.com

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)

June 2 at 8:00 AM | accessnewswire.com

Investors in Treace Medical Concepts, Inc. (TMCI): Protect Your Rights - Contact Levi & Korsinsky Before June 10, 2025

June 2 at 7:30 AM | accessnewswire.com

TMCI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Treace Medical Concepts, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!

June 2 at 7:00 AM | accessnewswire.com

Nuveen Asset Management LLC Has $3.52 Million Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI)

June 2 at 3:58 AM | marketbeat.com

Millennium Management LLC Has $2.45 Million Stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI)

June 2 at 3:43 AM | marketbeat.com

Securities Lawsuit Alert: Treace Medical Concepts, Inc. (TMCI) Investors - Contact Levi & Korsinsky Before June 10, 2025

June 1 at 5:45 PM | accessnewswire.com

TMCI DEADLINE NOTICE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Treace Medical Concepts, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 10 Deadline in Securities Class Action - TMCI

June 1 at 5:17 PM | accessnewswire.com

TMCI Deadline: Rosen Law Firm Urges Treace Medical Concepts, Inc. ...

June 1 at 11:20 AM | gurufocus.com

TMCI Deadline: Rosen Law Firm Urges Treace Medical Concepts, Inc. (NASDAQ: TMCI) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

June 1 at 10:02 AM | businesswire.com

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Treace Medical Concepts, Inc of Class Action Lawsuit and Upcoming Deadlines - TMCI

June 1 at 10:00 AM | prnewswire.com

Did You Lose Money on Treace Medical Concepts, Inc. (TMCI)? Levi & Korsinsky Urges Investors to Act Before June 10, 2025

June 1 at 9:45 AM | accessnewswire.com

Class Action Alert: Levi & Korsinsky Reminds Treace Medical Concepts, Inc. (TMCI) Investors of June 10, 2025 Deadline

June 1 at 7:30 AM | accessnewswire.com

TMCI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Treace Medical Concepts, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

June 1 at 7:00 AM | accessnewswire.com

Class Action Alert: Levi & Korsinsky Reminds Treace Medical Concepts, Inc. (TMCI) Investors of June 10, 2025 Deadline

May 31 at 6:01 PM | accessnewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

MGRM, TMCI, CLPT, and OM Company Descriptions

ClearPoint Neuro NASDAQ:CLPT

$11.84 +0.04 (+0.30%)

As of 03:50 PM Eastern

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Monogram Orthopaedics NASDAQ:MGRM

$2.40 -0.01 (-0.21%)

As of 03:50 PM Eastern

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas.

Outset Medical NASDAQ:OM

$17.75 +0.18 (+1.01%)

As of 03:51 PM Eastern

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Treace Medical Concepts NASDAQ:TMCI

$5.72 -0.03 (-0.44%)

As of 03:50 PM Eastern

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time